Search LFST
LifeStance Health Group, Inc.
Nasdaq · CIK 1845257
Last close11.83
Daily change-0.08 (-0.67%)
10 Years gain-45.98%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
LFST · STANDARD
SIC 8000 · Services-Health Services · Fiscal year end 1231
Fundamental
52.1Momentum
80.9Acceleration
80.9Confidence
85.0Annual Revenue6
Quarterly Revenue24
Annual CFO6
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth20.5 / 25
Quality18.2 / 25
Capital Efficiency1.5 / 20
Balance Sheet9.3 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 6.1767 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 0.8619%.
Key Metrics
Revenue Growth TTM23%OK
Revenue CAGR 3Y18.33%OK
Gross Margin100%OK
Operating Margin3.71%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC2.46%OK
Incremental Operating Margin 3Y32.99%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-0.86%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $1.42B | $1.42B | $24.15M | $146.15M | $110.03M | 100% | 1.7% | 7.73% | 1.2% | 391.14M |
| 2025 FY Dec 31, 2024 | $1.25B | $1.25B | -$31.61M | $107.26M | $85.69M | 100% | -2.53% | 6.85% | -1.55% | 379.15M |
| 2025 FY Dec 31, 2023 | $1.06B | $1.06B | -$189.13M | -$16.88M | -$57.40M | 100% | -17.92% | -5.44% | -9.1% | 367.46M |
| 2024 FY Dec 31, 2022 | $859.54M | $859.54M | -$210.17M | $52.79M | -$26.47M | 100% | -24.45% | -3.08% | -10.37% | 355.28M |
| 2023 FY Dec 31, 2021 | n/a | $667.51M | -$286.35M | $9.42M | -$85.07M | n/a | n/a | n/a | n/a | 327,523 |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.55B | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-338107, 0001193125-25-269712 |
| Revenue Growth TTM | 23% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-338107, 0001193125-25-269712 |
| Revenue CAGR 3Y | 18.33% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-071462 |
| Revenue CAGR 5Y | 46.3% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-071462 |
| Gross Profit CAGR 3Y | 18.33% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-071462 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001193125-26-338107, 0001193125-25-269712 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 100% | Gross Profit / Revenue | OK | 0001193125-26-338107, 0001193125-25-269712 |
| Operating Margin | 3.71% | Operating Income / Revenue | OK | 0001193125-26-338107, 0001193125-25-269712 |
| ROIC | 2.46% | NOPAT / Average Invested Capital | OK | 0001193125-26-338107, 0001193125-25-269712 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-338107 |
| Interest Coverage | 5.66x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 1.38x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.82x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-338107 |